Wells Fargo & Company Reneo Pharmaceuticals, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,200 shares of RPHM stock, worth $2,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200
Previous 5,323
77.46%
Holding current value
$2,016
Previous $8,000
87.5%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RPHM
# of Institutions
63Shares Held
29.3MCall Options Held
51.7KPut Options Held
0-
Nea Management Company, LLC Timonium, MD4.79MShares$8.04 Million0.68% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.46MShares$5.81 Million3.46% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$5.03 Million0.55% of portfolio
-
Highbridge Capital Management LLC New York, NY2.92MShares$4.9 Million0.94% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$4.53 Million0.49% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $41.1M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...